Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Heart Journal|June 30, 2001
ST-segment depression in lead aVR predicts predischarge left ventricular dysfunction in patients with reperfused anterior acute myocardial infarction with anterolateral ST-segment elevationM Kosuge, K Kimura, T Ishikawa, et al.The Journal of Biological Chemistry|October 25, 1990
NB-598: a potent competitive inhibitor of squalene epoxidaseM Horie, Y Tsuchiya, M Hayashi, et al.European Journal of Pharmacology|August 15, 2000
In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonistS Ozaki, H Kawamoto, Y Itoh, et al.Journal of Applied Microbiology|January 15, 2013
Potential probiotic thermophiles isolated from mice after compost ingestionH Miyamoto, M Seta, S Horiuchi, et al.Physical Chemistry Chemical Physics : PCCP|August 10, 2011
In situ time-resolved XAFS study on the structural transformation and phase separation of Pt3Sn and PtSn alloy nanoparticles on carbon in the oxidation processY Uemura, Y Inada, K K Bando, et al.Journal of Cardiology|June 9, 1998
[Optimal reperfusion therapy in acute myocardial infarction: time to reperfusion and recanalization rate]Y Mochida, K Kimura, M Kosuge, et al.Journal of Cardiology|September 30, 1998
[A patient with disopyramide intoxication rescued by percutaneous cardiopulmonary support]K Yoshida, K Kimura, K Hibi, et al.Journal of Cardiology|July 1, 1996
[Clinical significance of additional ST segment elevation immediately after successful reperfusion in patients with anterior wall acute myocardial infarction]M Kosuge, K Kimura, T Ishikawa, et al.Molecular Pharmacology|July 11, 1998
J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive mannerM Yonemoto, T Satoh, H Arakawa, et al.Journal of Medicinal Chemistry|December 14, 2001
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library designT Honma, K Hayashi, T Aoyama, et al.Pageof 4